Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial.

Timothy J Whelan Keying Xu Jenna Wong Gregory Russell Pond Yi Zhang Melanie Spears Ranelle Salunga Elizabeth Mallon Karen J Taylor Annette Hasenburg Markopoulos Christos Luc Dirix Cornelis J H van de Velde Daniel W Rea Catherine A Schnabel Kai Treuner Jane Bayani

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

The TEAM trial represents the largest prognostic validation study for BCI to date and provides a more representative assessment of late DR risk to guide individualized treatment decision-making for HR+ patients with early-stage breast cancer.

Keyphrases

early stage
decision making
phase iii
study protocol
palliative care
phase ii
breast cancer risk
clinical trial
quality improvement
cross sectional
bone mineral density
combination therapy
radiation therapy
editorial comment
young adults
double blind
rectal cancer
smoking cessation